Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus

PLoS Neglected Tropical Diseases

Volumn 10, Issue 5, 2016, Pages

  Cao, Lei ^a,b,c   Fu, Shihong ^a,b   Gao, Xiaoyan ^a,b   Li, Minghua ^a,b   Cui, Shiheng ^a,b   Li, Xiaolong ^a,b   Cao, Yuxi ^a,b   Lei, Wenwen ^a,b   Lu, Zhi ^a,b   He, Ying ^a,b   Wang, Huanyu ^a,b   Yan, Jinghua ^c   Gao, George Fu ^c   Liang, Guodong ^a,b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; SA-14-14-2 VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; INFECTION CONTROL; JAPANESE ENCEPHALITIS; LETHAL DOSE; MOUSE; NONHUMAN; PHENOTYPE; PLAQUE ASSAY; REINFECTION; SEROCONVERSION; SERODIAGNOSIS; VIROGENESIS; VIRUS TRANSMISSION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL LINE; CROSS PROTECTION; CYTOPATHOGENIC EFFECT; ENCEPHALITIS, JAPANESE; FEMALE; GENETICS; HAMSTER; HUMAN; IMMUNOLOGY; JAPANESE ENCEPHALITIS VIRUS; MALE; NEWBORN; PHYSIOLOGY; VACCINE IMMUNOGENICITY; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CRICETINAE; CROSS PROTECTION; CYTOPATHOGENIC EFFECT, VIRAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; GENOTYPE; HUMANS; IMMUNOGENICITY, VACCINE; IMMUNOGLOBULIN M; JAPANESE ENCEPHALITIS VACCINES; MALE; MICE; MICE, INBRED BALB C; VACCINES, ATTENUATED;

EID: 84971647422     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004686     Document Type: Article

References (25)

1. Pierson T. C. D., Flaviviruses M. S., Knipe D. M. H., Philadelphia P. M., In Fields Virology2013;6 edn, pp. 747–94. Edited by Lippincott Williams & Wilkins.
2. Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer Past, present, and future of Japanese encephalitis. Emerg Infect Dis2009; 15(8): 1–7.
3. Le Flohic G, Porphyre V, Barbazan P, Gonzalez JP, Review of climate, landscape, and viral genetics as drivers of the Japanese encephalitis virus ecology. PLoS Negl Trop Dis2013; 7:e2208. doi: 10.1371/journal.pntd.000220824069463
4. Campbell CL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bulletin of the World Health Organization2011; 89:766–74,744A–744E (http://www.who.int/bulletin/volumes/89/10/10-085233/en/) doi: 10.2471/BLT.10.08523322084515
5. Hatz C, Editorial commentary: Boosting Japanese encephalitis vaccine. Clin Infect Dis2012; 55(6):835–6doi: 10.1093/cid/cis54822696016
6. Hills SL, Griggs AC, Fischer M, Japanese encephalitis in travelers from non-endemic countries, 1973–2008. Am J Trop Med Hyg2010; 82(5):930–6. doi: 10.4269/ajtmh.2010.09-067620439978
7. Halstead SB, Jacobson J, Plotkin SA, Orenstein WA, Offit PA, Japanese encephalitis vaccines. Vaccine, 5th edn, (eds). Elsevier: Phildelphia2008; 311–52.
8. Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, et al. Cross-protective capacity of Japanese encephalitis(JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis2013; 56(2):267–70. doi: 10.1093/cid/cis88323074319
9. Li MH, Fu SH, Chen WX, Wang HY, Guo YH, Liu QY, et al. Genotype V Japanese encephalitis virus is emerging. PLoS Neglected Tropical Diseases2011; 5: e1231doi: 10.1371/journal.pntd.000123121750744
10. Mohammed MA, Galbraith SE, Radford AD, Dove W, Takasaki T, Kurane I, et al. Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype. Infection, Genetics and Evolution2011; 11: 855–62. doi: 10.1016/j.meegid.2011.01.02021352956
11. Takhampunya R, Kim HC, Tippayachai B, Kengluecha A, Klein TA, Lee WJ, et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virology Journal2011; 8: 449doi: 10.1186/1743-422X-8-44921943222
12. Li MH, Fu SH, Chen WX, Wang HY, Cao YX, Liang GD, Molecular characterization of full-length genome of Japanese encephalitis virus genotype V isolated from Tibet, China.Biomed Environ Sci2014; 27(4):231–9. doi: 10.3967/bes2014.04624758751
13. Gao XY, Liu H, Li MH, Fu S, Liang G, Insights into the evolutionary history of Japanese encephalitis virus (JEV) based on whole-genome sequences comprising the five genotypes. Virol J2015; 12:43. doi: 10.1186/s12985-015-0270-z25884184
14. Tajima S, Yagasaki K, Kotaki A, Tomikawa T, Nakayama E, Moi ML, et al. In vitro Growth, Pathogenicity, and Serological Characteristics of the Japanese Encephalitis Virus Genotype V Muar strain.J Gen Virol2015; 96(9): 2661–9doi: 10.1099/vir.0.00021326048886
15. Wang LH, Fu SH, Zhang HL, Ye X, Yu D, Deng Z, et al. Identification and isolation of Genotype-I Japanese encephalitis virus from encephalitis patients. Virology Journal2010; 7: 345. doi: 10.1186/1743-422X-7-34521108846
16. Pan XL, Liu H, Wang HY, Fu SH, Liu HZ, Zhang HL, et al. Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol2011; 85:9847–53. doi: 10.1128/JVI.00825-1121697481
17. Wang LH, Fu SH, Wang HY, Liang XF, Cheng JX, Jing HM, et al. Japanese encephalitis outbreak, Yuncheng,China, 2006. Emerg Infect Dis2007;13(7):1123–5. doi: 10.3201/eid1307.07001018214202
18. Liu X, Yu Y, Li M, Liang G, Wang H, Jia L, et al. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.Vaccine. 2011;29(11): 2127–30. doi: 10.1016/j.vaccine.2010.12.10821237278
19. Fan YC, Chen JM, Chiu HC, Chen YY, Lin JW, Shih CC, et al. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine. PLoS Negl Trop Dis2012; 6(9):e1834. doi: 10.1371/journal.pntd.000183423029592
20. de Wispelaere M, Frenkiel MP, Desprès P, A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence. J Virol. 2015; 89(11):5862–75. doi: 10.1128/JVI.00358-1525787283
21. Yun SI, Lee YM, Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother2014;10(2):263–79. doi: 10.4161/hv.2690224161909
22. Nah JJ, Yang DK, Kim HH, Song JY, The present and future of veterinary vaccines for Japanese encephalitis in Korea. Clin Exp Vaccine Res. 2015Jul;4(2):130–6. doi: 10.7774/cevr.2015.4.2.13026273571
23. Kim H, Cha GW, Jeong YE, Lee WG, Chang KS, Roh JY, et al. Detection of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea. PLoS One. 2015; 6;10(2):e0116547. doi: 10.1371/journal.pone.011654725658839
24. Gao X, Li X, Li M, Fu S, Wang H, Fu S, Wang H, Lu Z, et al. Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011. PLoS Negl Trop Dis2014; 8(8): e3015. doi: 10.1371/journal.pntd.000301525121596
25. Feng Yun, Fu Shihong, Zhang Hailin, Petersen LR, Zhang B, Gao X, et al. High Incidence of Japanese Encephalitis, Southern China; Emerg Infect Dis2013; 19(4):672–3. doi: 10.3201/eid1904.12013723750863